leisure time -WSS

leisure time

author：Wikipedia 2025-10-01 04:10:46 - browse：41

When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn’t biotech supposed to bounce back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain the story of Svetlana Mojsov, a chemist who played a vital role in the discovery of GLP-1 who has spent decades fighting for proper recognition. We also discuss the latest news in the life sciences, including the FDA hearing on a BrainStorm Cell Therapeutics’ polarizing ALS treatment, the end of the road for a once-vaunted drug developer, and the sorry state of biotech stocks.

For more on what we cover, here’s the Mojsov story; here’s the latest on BrainStorm; here’s the news on Intercept Pharmaceuticals; here’s more on the biotech market; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Intercept Pharmaceuticals sells itself for less than $1 billion

WSS

Ionis has late

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Ionis has late

A new deal aims to ramp up use of AI in rehab care decisions

Menendez indictment could see pharma lose a key ally

EMA weighs against approval for Mirati's lung cancer drug

leisure time

leisure time

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Virginia high school admissions case could be legal follow

Why do women spend more than men on medical expenses?

Duchenne breakthrough therapy leaves behind pioneering families

Would Medicare drug price negotiations stall in a shutdown?

Novavax promises a turnaround & Lilly roils the obesity market

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

Dobbs anniversary: the lost opportunity of abortion as health care

New chief aims to remake Sanofi Genzyme

knowledge

Listen: BridgeBio's big week & Lilly's Alzheimer's data

Pfizer's RSV vaccine recommended for approval in Europe

It's time to take a new tack for treating Alzheimer's

Medicare drug price negotiation program allowed for now

Data show record exodus of life scientists from academia

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

entertainment

focus

entertainment

entertainment